Last updated: October 04, 2026

Application No. 17/906,288

TREATMENT METHODS

Final Rejection

Filed

Sep 14, 2022

Priority

Mar 14, 2020 — AU 2020900782 +1 more

Examiner

PECKHAM, RICHARD GRANT

Art Unit

1627

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Levon Michael Khachigian

OA Round

2 (Final)

Interview Optional

— +35.1% interview lift. Examiner has a relatively high allowance rate (68%); +35.1% interview lift. A written response may suffice.

Based on 135 resolved cases, 2023–2026

Examiner Intelligence

PECKHAM, RICHARD GRANT View full profile →

Grants 68% — above average

Career Allowance Rate

92 granted / 135 resolved

+8.1% vs TC avg

Strong +35% interview lift

Without

With

+35.1%

Interview Lift

resolved cases with interview

Typical timeline

3y 3m

Avg Prosecution

69 currently pending

Career history

188

Total Applications

across all art units

Statute-Specific Performance

§101

2.9%

-37.1% vs TC avg

§103

28.8%

-11.2% vs TC avg

§102

16.1%

-23.9% vs TC avg

§112

30.3%

-9.7% vs TC avg

Black line = Tech Center average estimate • Based on career data from 135 resolved cases

Prosecution Timeline

Sep 14, 2022

Application Filed

Nov 28, 2025

Non-Final Rejection mailed

Apr 24, 2026

Response Filed

Apr 24, 2026

Response after Non-Final Action

Jun 03, 2026

Response Filed

Jul 21, 2026

Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/641,877

Patent 12748101

COMPOSITION AND METHOD FOR INHIBITING BORC COMPLEX TO TREAT CANCERS WITH NF1 DEFICIENCY AND DYSREGULATED RAS SIGNALING

4y 6m to grant Granted Sep 29, 2026

18/038,367

Patent 12735425

6,7-DIHYDRO-PYRANO[2,3-d]PYRIMIDINE INHIBITORS OF KRAS G12C MUTANT

3y 3m to grant Granted Sep 15, 2026

18/006,070

Patent 12728170

COMPOUNDS CAPABLE OF BINDING TO PROTEINS AND CONJUGATES OBTAINED FROM THESE COMPOUNDS

3y 7m to grant Granted Sep 08, 2026

17/978,286

Patent 12724175

CONTACT LENS WITH OPTICAL PROPHYLAXIS

3y 10m to grant Granted Sep 01, 2026

17/906,653

Patent 12703691

PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND THEIR USE

3y 10m to grant Granted Aug 11, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4

Expected OA Rounds

68%

Grant Probability

99%

With Interview (+35.1%)

3y 3m (~0m remaining)

Median Time to Grant

Moderate

PTA Risk

Based on 135 resolved cases by this examiner. Grant probability derived from career allowance rate.